Hyperparathyroidism in chronic kidney disease: complexities within the commonplace
- PMID: 22930877
- PMCID: PMC4952121
- DOI: 10.7861/clinmedicine.12-4-333
Hyperparathyroidism in chronic kidney disease: complexities within the commonplace
Abstract
Secondary hyperparathyroidism in patients with chronic kidney disease (CKD) is common and usually caused by associated metabolic abnormalities, in particular, hypocalcaemia and hyperphosphataemia. Nevertheless, other causes of hyperparathyroidism can exist concurrently with CKD, challenging diagnostic interpretation and therapeutic intervention. We present four cases of hyperparathyroidism in patients with CKD that highlight some of these dilemmas.
Figures



Similar articles
-
Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.J Manag Care Pharm. 2007 Jun;13(5):397-411. doi: 10.18553/jmcp.2007.13.5.397. J Manag Care Pharm. 2007. PMID: 17605511 Free PMC article. Review.
-
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.Endocr Pract. 2008 Jan-Feb;14(1):18-27. doi: 10.4158/EP.14.1.18. Endocr Pract. 2008. PMID: 18238737 Review.
-
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16. Clin J Am Soc Nephrol. 2015. PMID: 25516917 Free PMC article.
-
Secondary hyperparathyroidism among Nigerians with chronic kidney disease.Afr Health Sci. 2018 Jun;18(2):446-457. doi: 10.4314/ahs.v18i2.30. Afr Health Sci. 2018. PMID: 30602972 Free PMC article.
-
Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.Nutrients. 2013 Apr 19;5(4):1336-48. doi: 10.3390/nu5041336. Nutrients. 2013. PMID: 23603995 Free PMC article.
Cited by
-
Single-cell RNA sequencing reveals the role of cell heterogeneity in the sex difference in primary hyperparathyroidism.Front Endocrinol (Lausanne). 2023 Mar 7;14:1165890. doi: 10.3389/fendo.2023.1165890. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36960393 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical